Literature DB >> 32232807

[Olfactory Dysfunctions: References to Neuropsychiatric Disorders and Diagnostics].

Sylvia Waldmann1, Katrin T Lübke2, Michael Pentzek3, Bettina M Pause2.   

Abstract

Past research has revealed a variety of olfactory deficits associated with psychiatric and neurodegenerative disorders. These deficits are evident in psychophysical olfactory testing as well as neurophysiological and neuroanatomical examinations. The specific type of olfactory dysfunction appears disorder specific. For example, with regard to affective disorders, the functional and anatomical overlap between olfactory and emotion-specific brain areas has been suggested as a major underlying factor for olfactory dysfunction. Based on converging evidence of changes in olfactory perception related to Major Depression, Schizophrenia, Alzheimer's and Parkinson's Disease, olfactory testing has been discussed as an important additional diagnostic marker. Hence, valid methods for objective and reliable olfactory testing as well as guidelines for the interpretation of the respective diagnostic findings are required. The aim of this review is to provide an overview of reported olfactory deficits in psychiatric and neurodegenerative disorders. In addition, a selection of olfactory tests, available in German-speaking countries, with regard to the respective disorder-related olfactory deficit in question are presented and classified. Original data regarding an empirical validation of the Düsseldorf Odour Discrimination Test in a clinical population are presented. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2020        PMID: 32232807     DOI: 10.1055/a-1003-6798

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  1 in total

1.  Aerobic Exercise Improves Methamphetamine-Induced Olfactory Dysfunction Through α-Synuclein Intervention in Male Mice.

Authors:  Zhuo Wang; Rui Zheng; Xiaohan Wang; Xuekun Huang; Jian Huang; Cihang Gu; Yitong He; Shuo Wu; Jingyuan Chen; Qintai Yang; Pingming Qiu
Journal:  Front Mol Neurosci       Date:  2022-05-02       Impact factor: 5.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.